Okklo Life Sciences Overview
- Headquarters
- Nijmegen, Gelderland, Nl
- Website
- okklo.com
- Industry
- Pharmaceutical Manufacturing
- Employees
- 3
- Founded
- 2011
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
About Okklo Life Sciences
Okklo life sciences BV is a privately held biopharmaceutical company developing novel therapeutic solutions using cyclodextrin-based technologies. The current programs are focussed on lysosomal storage disorders and cardiovascular disorders. The company was founded in December 2011 by a group of life-sciences experts previously involved in the development and approval of sugammadex (Bridion™), the first modified cyclodextrin marketed as a drug product. We are continuously looking for collaborations and partnering opportunities with public and private partners - please visit our website to learn more about our technology platform strategy and development pipeline.
Okklo Life Sciences Contact Details
- People in AeroLeads
- 2
- With contact data
- 1
- Email contacts
- 1
- 50.0% coverage
Okklo Life Sciences Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Stephan Peters | Life Sciences R&D Specialist | Amsterdam, North Holland, Netherlands |
Email
|
| Alex Zwiers | General Manager Benelux Productlife |
View
|
Employees by Management Level
Individual contributor
3 profiles
Manager
1 profile
Compare Similar Companies to Okklo Life Sciences
Mdxhealth
Biotechnology Research
Vaxxinova
Veterinary Services
Binnovate Digital
Marketing Services
Enzyre B.V.
Medical Equipment Manufacturing
Alveron Pharma
Medical Practices
pinkRF - The RF Energy Company
Semiconductor Manufacturing
MEDIP ANALYTICS
Research Services
PharmaCytics
Pharmaceutical Manufacturing
Innogreen-Chem BV
Chemical Manufacturing
Saillant Therapeutics
Biotechnology Research